ArticleOncoimmunology
PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy.
Sietse J Luk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
pooled itcites it